Our top pick for
Aethlon Medical Inc is a medical devices business based in the US. Aethlon Medical shares (AEMD) are listed on the NASDAQ and all prices are listed in US Dollars. Aethlon Medical employs 10 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$3.58|
|52-week range||$1.32 - $7.13|
|50-day moving average||$3.71|
|200-day moving average||$3.52|
|Wall St. target price||$10.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.67|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||-1.10%|
|1 month (2021-09-19)||N/A|
|3 months (2021-07-23)||-35.14%|
|6 months (2021-04-23)||86.46%|
|1 year (2020-10-22)||111.83%|
|2 years (2019-10-22)||-9.37%|
|3 years (2018-10-22)||247.57%|
|5 years (2016-10-21)||4.79|
|Gross profit TTM||$659,104|
|Return on assets TTM||-25.35%|
|Return on equity TTM||-42.98%|
|Market capitalisation||$52.8 million|
TTM: trailing 12 months
There are currently 506,491 Aethlon Medical shares held short by investors – that's known as Aethlon Medical's "short interest". This figure is 95.7% up from 258,792 last month.
There are a few different ways that this level of interest in shorting Aethlon Medical shares can be evaluated.
Aethlon Medical's "short interest ratio" (SIR) is the quantity of Aethlon Medical shares currently shorted divided by the average quantity of Aethlon Medical shares traded daily (recently around 4.6 million). Aethlon Medical's SIR currently stands at 0.11. In other words for every 100,000 Aethlon Medical shares traded daily on the market, roughly 110 shares are currently held short.
However Aethlon Medical's short interest can also be evaluated against the total number of Aethlon Medical shares, or, against the total number of tradable Aethlon Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aethlon Medical's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Aethlon Medical shares in existence, roughly 30 shares are currently held short) or 0.0365% of the tradable shares (for every 100,000 tradable Aethlon Medical shares, roughly 37 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aethlon Medical.
Find out more about how you can short Aethlon Medical stock.
We're not expecting Aethlon Medical to pay a dividend over the next 12 months.
Aethlon Medical's shares were split on a 1:15 basis on 14 October 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aethlon Medical shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Aethlon Medical shares which in turn could have impacted Aethlon Medical's share price.
Over the last 12 months, Aethlon Medical's shares have ranged in value from as little as $1.32 up to $7.13. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aethlon Medical's is 0.5672. This would suggest that Aethlon Medical's shares are less volatile than average (for this exchange).
Aethlon Medical, Inc. , a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.